SEC Form 4 · accession 0001104659-18-051518
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antony C. Mattessich
Officer — President and CEO · Director
Period of report
Aug 10, 2018
Accepted (ET)
Aug 13, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2018 | P | 16,900 | $6.23 | A | 37,900 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List Exhibit 24.1 - Power of Attorney